Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Byron Smith
AddedMar 31, 2024
UpdatedMay 31, 2026
Byron Smith

Byron Smith

Board Member, AgTech Accelerator

LinkedIn

Byron Smith's Career

AgTech Accelerator
AgTech Accelerator

Triangle (historical), NC, US

Board Member· Board
NuSirt Sciences
NuSirt Sciences

Nashville, TN, US

Board Member· Board
Orig3N
Orig3N

Boston, MA, US

Board Member· Board
Silicon Ranch
Silicon Ranch

Nashville, TN, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Byron Smith's Career

AgTech Accelerator
AgTech Accelerator
Investment FirmInvestment Firm62016Triangle (historical), NC, US
Board Member· Board

Leadership at AgTech Accelerator

Kristina BurowKristina BurowBoard Member
Joseph Cook Jr \"Joe\"Joseph Cook Jr \"Joe\"Board Member

Similar to AgTech Accelerator

HudsonAlpha AgTechHudsonAlpha AgTechMadison, WI, USest. 2022HudsonAlpha AgTechMadison, WI, US · est. 2022

Madison-based HudsonAlpha AgTech Accelerator empowers agri-tech startups with coaching, financing, and connections.

Investment Firm50
Iowa AgriTech AcceleratorIowa AgriTech AcceleratorDes Moines, IA, USest. 2017Iowa AgriTech AcceleratorDes Moines, IA, US · est. 2017

Iowa-based AgriTech Accelerator: Mentor-led platform for innovative AgTech startups.

Investment Firm7
Ag Innovation Development GroupAg Innovation Development GroupMemphis, TN, USest. 2013Ag Innovation Development GroupMemphis, TN, US · est. 2013

Ag Innovation Development Group: Commercializing early-stage agri-tech for efficient farming and investor returns.

Investment Firm7
Happy FarmHappy FarmKyiv, Kyiv Oblast, UAest. 2012Happy FarmKyiv, Kyiv Oblast, UA · est. 2012

Accelerating startups globally with mentorship, investment, and tech commercialization.

Investment Firm19
NuSirt Sciences
NuSirt Sciences
Public$16M52007Nashville, TN, US
Board Member· Board

Leadership at NuSirt Sciences

Joe Cook JrJoe Cook JrBoard Member
Michael ZemelMichael ZemelFounder
Brian LadenBrian LadenBoard Member

Similar to NuSirt Sciences

NuvOx PharmaNuvOx PharmaTucson, AZ, USPharmaceuticalsest. 2008NuvOx PharmaTucson, AZ, US · est. 2008

NuvOx Pharma, an Arizona-based pharmaceutical company, develops oxygen-delivering drugs for stroke, oncology, and sickle cell crisis.

Series B · $19M6
Nested TherapeuticsNested TherapeuticsCambridge, MA, USTherapeuticsest. 2021Nested TherapeuticsCambridge, MA, US · est. 2021

Nested Therapeutics: A biotech innovator designing impactful therapeutics through creative service.

Series A · $125M50
NeurelisNeurelisSan Diego, CA, USPharmaceuticalsest. 2007NeurelisSan Diego, CA, US · est. 2007

Neurelis: A specialty pharmaceutical company targeting unmet medical needs with unique solutions.

Public · $206.1M138
Orig3N
Orig3N
Series B$76.2M332014Boston, MA, US
Board Member· Board

Leadership at Orig3N

Clay ThorpClay ThorpBoard Member
Kate BlanchardKate BlanchardCo-Founder
Robin SmithRobin SmithCEO

Similar to Orig3N

InvitaeInvitaeSan Francisco, CA, USGenetic Testingest. 2010InvitaeSan Francisco, CA, US · est. 2010

Invitae Corp., a global genetic information company, specializes in diagnostics, oncology, pediatrics, and hereditary screening.

Public · $2.5B1.7k
Cogent BiosciencesCogent BiosciencesWaltham, MA, USBiotech, Therapiesest. 2014Cogent BiosciencesWaltham, MA, US · est. 2014

US-based Cogent Biosciences develops biotech solutions for genetically driven diseases.

Public · $692.7M138
GeneticaGeneticaSan Francisco, CA, USGene Testingest. 2017GeneticaSan Francisco, CA, US · est. 2017

San Francisco-based Genetica pioneers in gene testing technology for precision medicine in Asia.

Seed · $2.5M75
23andMe23andMeSunnyvale, CA, USGenetic Testingest. 200623andMeSunnyvale, CA, US · est. 2006

23andMe: A biotech firm offering direct-to-consumer genetic testing for ancestry and health predispositions.

Public · $1.1B816
Silicon Ranch
Silicon Ranch
Private Equity$1.6B2702011Nashville, TN, US
Board Member· Board

Recent news

Axiado claims its chip can prevent cyberattacksTechCrunch · 2024

Leadership at Silicon Ranch

Reagan FarrReagan FarrBoard Member
Matt KisberMatt KisberBoard Member
Philip BredesenPhilip BredesenBoard Member
Susan M. WardSusan M. WardBoard Member

Byron Smith's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Byron Smith

Casey BaughCasey BaughCo-Founder · Sandlot PartnersJames SlavetJames SlavetBoard Member · RedfinBilly SmithBilly SmithBoard Member · Thaler MachineBrett RosenBrett RosenBoard Member · WellthieBobby McDonaldBobby McDonaldCo-Founder · AmstatzMark DonnellyMark DonnellyBoard Member · Montage